THE BioMed Co., Ltd. (KOSDAQ:214610)
South Korea · Delayed Price · Currency is KRW 4,540.00
+25.00 (0.55%)
At close: Sep 18, 2025
THE BioMed Revenue
THE BioMed had revenue of 494.10M KRW in the quarter ending June 30, 2025, a decrease of -78.18%. This brings the company's revenue in the last twelve months to 1.71B, down -76.31% year-over-year. In the year 2024, THE BioMed had annual revenue of 4.64B, down -13.55%.
Revenue (ttm)
1.71B
Revenue Growth
-76.31%
P/S Ratio
22.05
Revenue / Employee
35.69M
Employees
48
Market Cap
37.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.64B | -727.32M | -13.55% |
| Dec 31, 2023 | 5.37B | -10.74B | -66.69% |
| Dec 31, 2022 | 16.11B | -14.19B | -46.83% |
| Dec 31, 2021 | 30.30B | -15.37B | -33.65% |
| Dec 31, 2020 | 45.67B | 41.57B | 1,014.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |